Must climb back above support zones 🤖ACST broke below extreme support levels, but still holding above RSI support so all hope is not lost.
once be break back above support (1.88 area) then my targets to the upside are 2.92-4.41-6.47
−5.09USD
−42.43 MUSD
6.74 M
About Acasti Pharma, Inc.
Sector
CEO
Prashant Kohli
Headquarters
Princeton
Website
Founded
2002
ISIN
CA00430K8656
FIGI
BBG001NMDXS6
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.
Inside bar Squeeze on ACST IBS squeeze refer to your resources and follow the trend we got day 1 and day 2 now we should see DAY 3 for a zombie move
ACSTAcasti Pharma Inc (NASDAQ:ACST) has been struggling, as have most small bio caps stocks lately, but there are some signs of reversal in this downward path. What needs to be watched from here out is whether it is still being accumulated. The bounce off the recent sell-off lows could potentially be th
ACST 1W Swing editiontest
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The
Potential ACST Breakout to Gap UpGap from 3.21 to 2.94 from end of August as a result of a stock split.
RSI on the the 1D chart just passed 30; MACD recently went green and today served as a solid buy signal. Could close the gap above.
SL 2.10 or 2 depending on risk tolerance.
ACSTAcasti Pharma Inc (NASDAQ:ACST) is also bottoming out. This one could easily run to $3 in a heartbeat, just needs a little love and attention. Bullish MACD crossover on 4h chart.
Acasti trading in a range. Might be good for a short swing tradeAs per title, looks like it might be heading back up in its range. Already up 20% off the bottom with possibly another 20% to go. Just crossed up over its 20 Day Moving Average which is often a good sign.
Buyer beware. Keep your stops tight especially as it nears the top.
ACST Swing trade idea R/R 1/3ACST is currently located at the bottom of the value zone (~ $0.38 area) , as you can see from the chart price bounced multiple times to the upside from the bottom of the value zone ,also notice the indicators below .In my estimation we have a higher probability for ACST to start moving higher and r
Acst deep value areaI love this chart on acst only if it holds .38 giving you a perfect place for a stop loss that's what makes it so great paired with the bullish cypher and the massive inverse h&s
Potential upside following within channelDowntrend rejection at .48 would signal a triple bottom at the 3 month chart, signaling a possible reversal to .61 resistance. There are key resistance levels at around .57 that need to break. If .61 breaks, .67 becomes next resistance. There is a pretty clear channel between .48 and .61 for swing t
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ACST is 3.19 USD — it has decreased by 4.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Acasti Pharma, Inc. stocks are traded under the ticker ACST.
Acasti Pharma, Inc. is going to release the next earnings report on Jun 18, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Acasti Pharma, Inc. has a max estimate of 6.00 USD and a min estimate of 6.00 USD.
ACST earnings for the last quarter are −0.43 USD whereas the estimation was −0.26 USD which accounts for −65.38% surprise. Estimated earnings for the next quarter are −0.23 USD. See more details about Acasti Pharma, Inc. earnings.
Yes, you can track Acasti Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ACST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Acasti Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.